S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Warren Buffett uses his annual letter to warn about Wall Street and recount Berkshire's successes
Free Stock Analysis Report: See The True Value of Any Stock (Ad)
MarketBeat Week in Review – 2/19 - 2/23
A collection of the insights Warren Buffett offered in his annual letter Saturday
Free Stock Analysis Report: See The True Value of Any Stock (Ad)
West Africa bloc lifts coup sanctions on Niger in a new push for dialogue to resolve tensions
West Africa's ECOWAS bloc says it's lifting sanctions imposed on Niger over last year’s coup in a new push for dialogue
Free Stock Analysis Report: See The True Value of Any Stock (Ad)
Macron booed by French farmers who blame him for not doing enough to support agriculture
MILAN FASHION PHOTOS: Ferragamo, Dolce&Gabbana conceal and reveal, balance transparency with cover
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Warren Buffett uses his annual letter to warn about Wall Street and recount Berkshire's successes
Free Stock Analysis Report: See The True Value of Any Stock (Ad)
MarketBeat Week in Review – 2/19 - 2/23
A collection of the insights Warren Buffett offered in his annual letter Saturday
Free Stock Analysis Report: See The True Value of Any Stock (Ad)
West Africa bloc lifts coup sanctions on Niger in a new push for dialogue to resolve tensions
West Africa's ECOWAS bloc says it's lifting sanctions imposed on Niger over last year’s coup in a new push for dialogue
Free Stock Analysis Report: See The True Value of Any Stock (Ad)
Macron booed by French farmers who blame him for not doing enough to support agriculture
MILAN FASHION PHOTOS: Ferragamo, Dolce&Gabbana conceal and reveal, balance transparency with cover
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Warren Buffett uses his annual letter to warn about Wall Street and recount Berkshire's successes
Free Stock Analysis Report: See The True Value of Any Stock (Ad)
MarketBeat Week in Review – 2/19 - 2/23
A collection of the insights Warren Buffett offered in his annual letter Saturday
Free Stock Analysis Report: See The True Value of Any Stock (Ad)
West Africa bloc lifts coup sanctions on Niger in a new push for dialogue to resolve tensions
West Africa's ECOWAS bloc says it's lifting sanctions imposed on Niger over last year’s coup in a new push for dialogue
Free Stock Analysis Report: See The True Value of Any Stock (Ad)
Macron booed by French farmers who blame him for not doing enough to support agriculture
MILAN FASHION PHOTOS: Ferragamo, Dolce&Gabbana conceal and reveal, balance transparency with cover
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Warren Buffett uses his annual letter to warn about Wall Street and recount Berkshire's successes
Free Stock Analysis Report: See The True Value of Any Stock (Ad)
MarketBeat Week in Review – 2/19 - 2/23
A collection of the insights Warren Buffett offered in his annual letter Saturday
Free Stock Analysis Report: See The True Value of Any Stock (Ad)
West Africa bloc lifts coup sanctions on Niger in a new push for dialogue to resolve tensions
West Africa's ECOWAS bloc says it's lifting sanctions imposed on Niger over last year’s coup in a new push for dialogue
Free Stock Analysis Report: See The True Value of Any Stock (Ad)
Macron booed by French farmers who blame him for not doing enough to support agriculture
MILAN FASHION PHOTOS: Ferragamo, Dolce&Gabbana conceal and reveal, balance transparency with cover

Repligen (RGEN) Earnings Date, Estimates & Call Transcripts

$196.52
+3.12 (+1.61%)
(As of 02/23/2024 ET)

Earnings Summary

Upcoming
Earnings Date
May. 7Estimated
Actual EPS
(Feb. 21)
$0.33
Consensus EPS
(Feb. 21)
$0.33
Skip Charts & View Estimated and Actual Earnings Data

RGEN Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

RGEN Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Repligen Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20244$0.30$0.75$0.46 
Q2 20244$0.31$0.83$0.50 
Q3 20244$0.38$0.85$0.52 
Q4 20244$0.44$0.91$0.57 
FY 202416$1.43$3.34$2.05 
Q1 20253$0.44$0.69$0.53 
Q2 20253$0.48$0.76$0.58 
Q3 20253$0.52$0.61$0.56 
Q4 20253$0.54$0.65$0.60 
FY 202512$1.98$2.71 $2.27

RGEN Earnings Date and Information

Repligen last posted its quarterly earnings data on February 21st, 2024. The biotechnology company reported $0.33 earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of $0.33. The firm had revenue of $155.74 million for the quarter, compared to analyst estimates of $155.38 million. Its revenue for the quarter was down 16.6% on a year-over-year basis. Repligen has generated $0.72 earnings per share over the last year ($0.72 diluted earnings per share) and currently has a price-to-earnings ratio of 272.9. Earnings for Repligen are expected to grow by 77.40% in the coming year, from $1.46 to $2.59 per share. Repligen has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 7th, 2024 based off prior year's report dates.

Repligen Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/7/2024
Estimated)
------- 
2/21/2024Q4 2023$0.33$0.33-$1.12$155.38 million$155.74 million    
10/31/2023Q3 2023$0.14$0.23+$0.09$0.14$140.68 million$141.20 million    
8/2/2023Q2 2023$0.49$0.53+$0.04$0.71$165.93 million$159.20 million    
5/2/2023Q1 2023$0.59$0.64+$0.05$0.77$181.43 million$182.70 million    
2/22/2023Q4 2022$0.58$0.68+$0.10$0.51$184.41 million$186.80 million    
11/1/2022Q3 2022$0.68$0.77+$0.09$0.83$192.01 million$200.74 million
8/2/2022Q2 2022$0.72$0.91+$0.19$0.94$189.06 million$207.63 million    
4/27/2022Q1 2022$0.72$0.92+$0.20$1.03$185.48 million$206.40 million    
2/17/2022Q4 2021$0.65$0.81+$0.16$1.12$178.27 million$186.52 million    
10/28/2021Q3 2021$0.64$0.78+$0.14$0.98$163.97 million$178.22 million    
7/26/2021Q2 2021$0.52$0.79+$0.27$0.94$144.24 million$162.96 million    
5/4/2021Q1 2021$0.42$0.68+$0.26$0.84$117.88 million$142.80 million  












Repligen Earnings - Frequently Asked Questions

When is Repligen's earnings date?

Repligen has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 7th, 2024 based off last year's report dates. Learn more on RGEN's earnings history.

Did Repligen beat their earnings estimates last quarter?

In the previous quarter, Repligen (NASDAQ:RGEN) reported $0.33 earnings per share (EPS) to hit the analysts' consensus estimate of $0.33. Learn more on analysts' earnings estimate vs. RGEN's actual earnings.

How can I listen to Repligen's earnings conference call?

The conference call for Repligen's latest earnings report can be listened to online. Listen to Conference Call

How can I read Repligen's conference call transcript?

The conference call transcript for Repligen's latest earnings report can be read online. Read Transcript

How much revenue does Repligen generate each year?

Repligen (NASDAQ:RGEN) has a recorded annual revenue of $638.76 million.

How much profit does Repligen generate each year?

Repligen (NASDAQ:RGEN) has a recorded net income of $185.96 million. RGEN has generated $0.72 earnings per share over the last four quarters.

What is Repligen's price-to-earnings ratio?

Repligen (NASDAQ:RGEN) has a trailing price-to-earnings ratio of 272.95 and a forward price-to-earnings ratio of 134.60. The price/earnings-to-growth ratio is 5.54.

What is Repligen's EPS forecast for next year?

Repligen's earnings are expected to grow from $1.46 per share to $2.59 per share in the next year, which is a 77.40% increase.


More Earnings Resources from MarketBeat

This page (NASDAQ:RGEN) was last updated on 2/25/2024 by MarketBeat.com Staff